Amedisys Inc (AMED)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	156,405	168,628	165,348	175,148	180,769	182,690	200,559	231,094	251,943	265,937	272,437	244,234	219,255	198,702	182,202	177,021	177,475	172,302	165,390	163,467
Revenue (ttm)	US$ in thousands	2,236,382	2,227,658	2,229,409	2,234,331	2,223,199	1,671,704	1,667,201	1,111,979	573,337	567,158	15,793	33,153	518,223	1,014,511	1,507,022	1,979,978	1,955,633	1,889,333	1,810,011	1,726,487
Operating profit margin		6.99%	7.57%	7.42%	7.84%	8.13%	10.93%	12.03%	20.78%	43.94%	46.89%	1,725.05%	736.69%	42.31%	19.59%	12.09%	8.94%	9.08%	9.12%	9.14%	9.47%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $156,405K ÷ $2,236,382K
= 6.99%

The operating profit margin for Amedisys Inc. has shown a gradually decreasing trend over the past quarters. In Q1 2022, the operating profit margin was the highest at 10.19%, but it has been consistently declining since then. The margins were relatively stable in Q2 and Q3 2022, ranging from 8.36% to 9.05%. However, there was a noticeable drop to 7.55% in Q2 2023, followed by a slight increase to 7.79% in Q3 2023, and then a further increase to 8.63% in Q4 2023.

This trend indicates potential challenges in maintaining profitability or controlling costs in recent quarters. Further analysis should be conducted to understand the factors contributing to these fluctuations and to develop strategies to improve the operating profit margin in the future.